vs
Garrett Motion Inc.（GTX）与登士柏西诺德（XRAY）财务数据对比。点击上方公司名可切换其他公司
登士柏西诺德的季度营收约是Garrett Motion Inc.的1.1倍（$961.0M vs $891.0M），Garrett Motion Inc.净利率更高（9.4% vs -15.2%，领先24.6%），登士柏西诺德同比增速更快（6.2% vs 5.6%），Garrett Motion Inc.自由现金流更多（$78.0M vs $60.0M），过去两年登士柏西诺德的营收复合增速更高（0.4% vs -1.3%）
盖瑞特动力（前身为霍尼韦尔交通系统部及霍尼韦尔涡轮增压技术部）是一家美国企业，核心业务为涡轮增压器及相关强制进气系统的工程研发与生产，产品覆盖小型乘用车、大型卡车、工业设备及工程机械等各类陆上交通工具，其前身可追溯至1954年亚利桑那州凤凰城的 Garrett AiResearch 工业部门。
登士柏西诺德是美国牙科设备及耗材制造商，业务覆盖全球120多个国家，在21个国家设有生产工厂。该公司前身为1993年Gendex公司以5.9亿美元收购登士柏国际后整合组建的企业，是全球牙科领域的重要供应商。
GTX vs XRAY — 直观对比
营收规模更大
XRAY
是对方的1.1倍
$891.0M
营收增速更快
XRAY
高出0.6%
5.6%
净利率更高
GTX
高出24.6%
-15.2%
自由现金流更多
GTX
多$18.0M
$60.0M
两年增速更快
XRAY
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $891.0M | $961.0M |
| 净利润 | $84.0M | $-146.0M |
| 毛利率 | 20.8% | 46.1% |
| 营业利润率 | 11.6% | -14.5% |
| 净利率 | 9.4% | -15.2% |
| 营收同比 | 5.6% | 6.2% |
| 净利润同比 | -16.0% | 66.0% |
| 每股收益（稀释后） | $0.42 | $-0.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GTXXRAY
| Q4 25 | $891.0M | $961.0M | ||
| Q3 25 | $902.0M | $904.0M | ||
| Q2 25 | $913.0M | $936.0M | ||
| Q1 25 | $878.0M | $879.0M | ||
| Q4 24 | $844.0M | $905.0M | ||
| Q3 24 | $826.0M | $951.0M | ||
| Q2 24 | $890.0M | $984.0M | ||
| Q1 24 | $915.0M | $953.0M |
净利润GTXXRAY
| Q4 25 | $84.0M | $-146.0M | ||
| Q3 25 | $77.0M | $-427.0M | ||
| Q2 25 | $87.0M | $-45.0M | ||
| Q1 25 | $62.0M | $20.0M | ||
| Q4 24 | $100.0M | $-430.0M | ||
| Q3 24 | $52.0M | $-494.0M | ||
| Q2 24 | $64.0M | $-4.0M | ||
| Q1 24 | $66.0M | $18.0M |
毛利率GTXXRAY
| Q4 25 | 20.8% | 46.1% | ||
| Q3 25 | 20.6% | 48.8% | ||
| Q2 25 | 19.8% | 52.4% | ||
| Q1 25 | 20.4% | 53.0% | ||
| Q4 24 | 21.6% | 49.3% | ||
| Q3 24 | 20.1% | 52.1% | ||
| Q2 24 | 20.8% | 51.9% | ||
| Q1 24 | 18.8% | 53.1% |
营业利润率GTXXRAY
| Q4 25 | 11.6% | -14.5% | ||
| Q3 25 | 11.3% | -24.1% | ||
| Q2 25 | 11.2% | -13.7% | ||
| Q1 25 | 9.7% | 7.2% | ||
| Q4 24 | 11.7% | -56.2% | ||
| Q3 24 | 9.2% | -48.6% | ||
| Q2 24 | 9.8% | 5.1% | ||
| Q1 24 | 8.9% | 4.4% |
净利率GTXXRAY
| Q4 25 | 9.4% | -15.2% | ||
| Q3 25 | 8.5% | -47.2% | ||
| Q2 25 | 9.5% | -4.8% | ||
| Q1 25 | 7.1% | 2.3% | ||
| Q4 24 | 11.8% | -47.5% | ||
| Q3 24 | 6.3% | -51.9% | ||
| Q2 24 | 7.2% | -0.4% | ||
| Q1 24 | 7.2% | 1.9% |
每股收益（稀释后）GTXXRAY
| Q4 25 | $0.42 | $-0.74 | ||
| Q3 25 | $0.38 | $-2.14 | ||
| Q2 25 | $0.42 | $-0.22 | ||
| Q1 25 | $0.30 | $0.10 | ||
| Q4 24 | $0.46 | $-2.09 | ||
| Q3 24 | $0.24 | $-2.46 | ||
| Q2 24 | $0.28 | $-0.02 | ||
| Q1 24 | $0.28 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $177.0M | $326.0M |
| 总债务越低越好 | — | $2.3B |
| 股东权益账面价值 | $-802.0M | $1.3B |
| 总资产 | $2.4B | $5.4B |
| 负债/权益比越低杠杆越低 | — | 1.70× |
8季度趋势，按日历期对齐
现金及短期投资GTXXRAY
| Q4 25 | $177.0M | $326.0M | ||
| Q3 25 | $230.0M | $363.0M | ||
| Q2 25 | $232.0M | $359.0M | ||
| Q1 25 | $130.0M | $398.0M | ||
| Q4 24 | $125.0M | $272.0M | ||
| Q3 24 | $96.0M | $296.0M | ||
| Q2 24 | $98.0M | $279.0M | ||
| Q1 24 | $196.0M | $291.0M |
总债务GTXXRAY
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GTXXRAY
| Q4 25 | $-802.0M | $1.3B | ||
| Q3 25 | $-813.0M | $1.5B | ||
| Q2 25 | $-812.0M | $2.0B | ||
| Q1 25 | $-700.0M | $2.0B | ||
| Q4 24 | $-673.0M | $1.9B | ||
| Q3 24 | $-778.0M | $2.5B | ||
| Q2 24 | $-725.0M | $3.1B | ||
| Q1 24 | $-735.0M | $3.3B |
总资产GTXXRAY
| Q4 25 | $2.4B | $5.4B | ||
| Q3 25 | $2.4B | $5.7B | ||
| Q2 25 | $2.4B | $6.1B | ||
| Q1 25 | $2.3B | $6.0B | ||
| Q4 24 | $2.3B | $5.8B | ||
| Q3 24 | $2.2B | $6.6B | ||
| Q2 24 | $2.2B | $6.9B | ||
| Q1 24 | $2.4B | $7.1B |
负债/权益比GTXXRAY
| Q4 25 | — | 1.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $99.0M | $101.0M |
| 自由现金流经营现金流 - 资本支出 | $78.0M | $60.0M |
| 自由现金流率自由现金流/营收 | 8.8% | 6.2% |
| 资本支出强度资本支出/营收 | 2.4% | 4.3% |
| 现金转化率经营现金流/净利润 | 1.18× | — |
| 过去12个月自由现金流最近4个季度 | $341.0M | $104.0M |
8季度趋势，按日历期对齐
经营现金流GTXXRAY
| Q4 25 | $99.0M | $101.0M | ||
| Q3 25 | $100.0M | $79.0M | ||
| Q2 25 | $158.0M | $48.0M | ||
| Q1 25 | $56.0M | $7.0M | ||
| Q4 24 | $131.0M | $87.0M | ||
| Q3 24 | $67.0M | $141.0M | ||
| Q2 24 | $126.0M | $208.0M | ||
| Q1 24 | $84.0M | $25.0M |
自由现金流GTXXRAY
| Q4 25 | $78.0M | $60.0M | ||
| Q3 25 | $90.0M | $40.0M | ||
| Q2 25 | $143.0M | $16.0M | ||
| Q1 25 | $30.0M | $-12.0M | ||
| Q4 24 | $109.0M | $36.0M | ||
| Q3 24 | $47.0M | $98.0M | ||
| Q2 24 | $109.0M | $156.0M | ||
| Q1 24 | $52.0M | $-9.0M |
自由现金流率GTXXRAY
| Q4 25 | 8.8% | 6.2% | ||
| Q3 25 | 10.0% | 4.4% | ||
| Q2 25 | 15.7% | 1.7% | ||
| Q1 25 | 3.4% | -1.4% | ||
| Q4 24 | 12.9% | 4.0% | ||
| Q3 24 | 5.7% | 10.3% | ||
| Q2 24 | 12.2% | 15.9% | ||
| Q1 24 | 5.7% | -0.9% |
资本支出强度GTXXRAY
| Q4 25 | 2.4% | 4.3% | ||
| Q3 25 | 1.1% | 4.3% | ||
| Q2 25 | 1.6% | 3.4% | ||
| Q1 25 | 3.0% | 2.2% | ||
| Q4 24 | 2.6% | 5.6% | ||
| Q3 24 | 2.4% | 4.5% | ||
| Q2 24 | 1.9% | 5.3% | ||
| Q1 24 | 3.5% | 3.6% |
现金转化率GTXXRAY
| Q4 25 | 1.18× | — | ||
| Q3 25 | 1.30× | — | ||
| Q2 25 | 1.82× | — | ||
| Q1 25 | 0.90× | 0.35× | ||
| Q4 24 | 1.31× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 1.97× | — | ||
| Q1 24 | 1.27× | 1.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GTX
暂无分部数据
XRAY
| Essential Dental Solutions | $372.0M | 39% |
| Equipment And Instruments | $160.0M | 17% |
| Implants And Prosthetics | $150.0M | 16% |
| CADCAM | $139.0M | 14% |
| Wellspect Healthcare | $88.0M | 9% |
| Orthodontics | $52.0M | 5% |
